In January 2025, Growthink Capital Research reported new venture funding of $9.07 billion, a significant increase compared to the $6.72 billion recorded in December 2024.
The month’s biggest funding event belonged to Infinite Reality ($3 billion) an innovation company designed to develop digital media and e-commerce through artificial intelligence, spatial computing, and other immersive technologies enabling brands and creators to fully control how they distribute content, engage audiences, and monetize their creations while maintaining ownership of their data.
Nineteen companies raised over $100 million in January. Other than Infinite Reality, the other eighteenth companies that raised the most are as follows:
- Helion ($425 million) a patented plasma accelerator technology designed to address the growing need for clean energy, enabling users to keep the environment clean around them.
- Treeline Biosciences ($421 million) a transformative precision medicine intended to treat cancer and other serious conditions, enabling medical professionals to cure cancer and other serious conditions.
- Kailera Therapeutics ($400 million) a biopharmaceutical company intended to deliver differentiated treatment options for obesity and related conditions, enabling patients to transform their lives and elevate their overall health.
- Innovaccer ($275 million) a healthcare data technology platform intended to deliver intelligent and connected experiences that advance health outcomes, enabling healthcare organizations to streamline clinical workflows, enhance care coordination, and improve patient outcomes.
- Colossal ($200 million) a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics, enabling environmental organizations to restore Earth to a healthier state, while also solving for future economies and biological necessities of the human condition.
- Tenvie Therapeutics ($200 million) a biotechnology platform designed to develop small molecules for treating neurological, cardiometabolic, and ophthalmic diseases, enabling targeted treatment of inflammation, metabolic dysfunction, and lysosomal dysfunction, addressing key aspects of disease progression.
- Tune Therapeutics ($175 million) an epigenetic programming platform designed to create new pathways for the treatment of disease, providing patients with treatments for pervasive and complex diseases.
- Loft Orbital ($170 million) a satellite deployment and management platform designed to democratize access to space by providing a simple, reliable, and affordable way to deploy and operate small satellites, enabling clients to focus on their mission rather than the engineering details.
- Inari ($144 million) a plant breeding platform designed to build a new and sustainable food system, enabling farmers to grow sustainable and efficient crops.
- Hippocratic AI ($141 million) a healthcare platform intended to improve healthcare accessibility and health outcomes in the world, enabling patients to get healthcare at home and improve their health without any hassle.
- Evergreen Nephrology ($130 million) a kidney transplant and care hospital intended to serve people suffering from kidney disease, enabling nephrologists to transform kidney care to improve patient quality of life and more healthy days at home.
- Ouro Medicines ($120 million) a therapeutic platform designed to develop immune reset treatments for chronic immune-mediated diseases, enabling patients with immune-mediated diseases to experience extended remissions without ongoing immunosuppression.
- Qventus ($105 million) a hospital management software designed for hospital teams to make better operational decisions in real-time, enabling clients to turn data into action, reduce manual work and grow revenue.
- Geneoscopy ($105 million) a diagnostics technology designed to treat digestive diseases and also offer cancer screening services, enabling doctors to prevent, detect, and guide treatment for gastrointestinal disease.
- Bluwhale ($100 million) an AI-based business intelligence SaaS platform designed to automate LiveOps, optimize revenue, and proactively reduce churn, enabling developers to improve the game’s overall performance.
- Instabase ($100 million) an applied artificial intelligence platform designed to address business challenges, enabling businesses to solve important problems such as intelligent document processing.
- Harbinger ($100 million) an electric vehicle technology designed to provide technologically progressive commercial vehicles and modernize the medium-duty vehicle industry, enabling car owners to reduce fuel consumption.
- OnPay ($100 million) a payroll management and compliance software designed to provide low-cost services to businesses, enabling small and medium-sized businesses to simplify payroll management.
The hottest sectors for funding during the month were Biotech, Healthtech, A.I./Machine Learning, Financial Software, and Business/Productivity Software.
Key funding events in each of these sectors for the month are below:
- Biotech deals included Treeline Biosciences ($421 million), Kailera Therapeutics ($400 million), Colossal ($200 million), Tenvie Therapeutics ($200 million), Tune Therapeutics ($175 million), Ouro Medicines ($120 million), A2 Biotherapeutics ($80 million), Francis Medical ($80 million), Normunity ($75 million), Ashvattha Therapeutics ($50 million), Hinge Bio ($30 million), Clear Labs ($30 million), General Proximity ($16 million), Granata Bio ($15 million), Aptitude ($10 million), and First Ascent Biomedical ($6 million).
- Healthtech deals included Innovaccer ($275 million), Hippocratic AI ($141 million), Qventus ($105 million), Eleos ($60 million), Lindus Health ($55 million), VideaHealth ($40 million), Solera Health ($40 million), Kode Health ($27 million), Prudentia Sciences ($7 million), HC1 ($6.2 million), Springbok Analytics ($5 million), and Peregrine Health ($5 million).
- A.I./Machine Learning deals included Bluwhale ($100 million), Instabase ($100 million), Rad AI ($60 million), Eve ($47 million), Qualified Health ($30 million), Observo AI ($15 million), Coram AI ($13.8 million), Lanai ($10 million), Palona AI ($10 million), and Backline ($9 million).
- Financial Software deals included Highnote ($90 million), Fundraise Up ($70 million), Clutch ($65 million), Method Financial ($41.5 million), Anchor ($20 million), Sydecar ($11 million), Nilus ($10 million), and Cedar Money ($9.9 million).
- Business/Productivity Software deals included OneBrief ($50 million), PrettyDamnQuick ($25 million), Pipe17 ($15.5 million), Belfry ($12 million), Ember Software ($10 million), Inka Entworks ($8.2 million), and Axoflow ($7 million).
If you’re looking for outside funding to grow your company, please don’t hesitate to call us at (213) 927-3968 or fill out Growthink Capital’s contact form here.